Parr Mcknight Wealth Management Group LLC Lowers Holdings in CME Group Inc. (NASDAQ:CME)

Parr Mcknight Wealth Management Group LLC trimmed its position in CME Group Inc. (NASDAQ:CME - Free Report) by 11.4% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,846 shares of the financial services provider's stock after selling 1,656 shares during the quarter. Parr Mcknight Wealth Management Group LLC's holdings in CME Group were worth $3,408,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of CME Group by 1.0% in the 4th quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock valued at $7,952,273,000 after acquiring an additional 326,623 shares during the period. Geode Capital Management LLC lifted its stake in CME Group by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock worth $1,946,717,000 after purchasing an additional 104,697 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in CME Group by 89.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after acquiring an additional 3,921,278 shares during the last quarter. Norges Bank acquired a new stake in CME Group during the fourth quarter worth $1,107,389,000. Finally, FIL Ltd increased its holdings in CME Group by 1.5% in the 4th quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock valued at $947,821,000 after purchasing an additional 61,908 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Stock Performance

CME Group stock opened at $275.64 on Thursday. The company has a market capitalization of $99.33 billion, a P/E ratio of 27.73, a P/E/G ratio of 3.74 and a beta of 0.44. The business has a 50 day moving average of $276.73 and a 200-day moving average of $258.73. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1 year low of $193.17 and a 1 year high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.61 by $0.19. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.56 billion. During the same period last year, the business earned $2.50 EPS. CME Group's quarterly revenue was up 10.4% compared to the same quarter last year. On average, equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date was Monday, June 9th. CME Group's payout ratio is 50.30%.

Insider Buying and Selling

In related news, Director Phyllis M. Lockett sold 1,060 shares of the business's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $277.88, for a total value of $294,552.80. Following the completion of the sale, the director owned 3,108 shares in the company, valued at $863,651.04. The trade was a 25.43% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Daniel G. Kaye sold 500 shares of the business's stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the completion of the sale, the director owned 3,668 shares of the company's stock, valued at $1,035,916.56. The trade was a 12.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 13,400 shares of company stock worth $3,680,610 in the last quarter. 0.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on the stock. JPMorgan Chase & Co. decreased their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Barclays upped their target price on shares of CME Group from $279.00 to $283.00 and gave the stock an "equal weight" rating in a research report on Wednesday, April 23rd. Royal Bank Of Canada reissued a "sector perform" rating and set a $269.00 price objective on shares of CME Group in a research note on Thursday, April 3rd. Piper Sandler raised their target price on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. Finally, Wall Street Zen upgraded shares of CME Group from a "sell" rating to a "hold" rating in a research report on Saturday, July 5th. Three research analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, CME Group has a consensus rating of "Hold" and a consensus price target of $259.87.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.